Literature DB >> 9328971

Hypertension in autosomal dominant polycystic kidney disease.

A B Chapman1, P A Gabow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9328971

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  15 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

Review 2.  Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes.

Authors:  Rainer Büscher; Anja K Büscher; Stefanie Weber; Julia Mohr; Bianca Hegen; Udo Vester; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2013-10-10       Impact factor: 3.714

Review 3.  Hypertension in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; Konrad Stepniakowski; Frederic Rahbari-Oskoui
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

Review 4.  Renal cystic diseases: diverse phenotypes converge on the cilium/centrosome complex.

Authors:  Lisa M Guay-Woodford
Journal:  Pediatr Nephrol       Date:  2006-07-06       Impact factor: 3.714

5.  Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization.

Authors:  Tatsuya Suwabe; Yoshifumi Ubara; Koki Mise; Toshiharu Ueno; Keiichi Sumida; Masayuki Yamanouchi; Noriko Hayami; Junichi Hoshino; Masahiro Kawada; Aya Imafuku; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Kenmei Takaichi
Journal:  J Am Soc Nephrol       Date:  2015-11-30       Impact factor: 10.121

6.  Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease.

Authors:  Guangfu Jia; Michelle Kwon; Huan Ling Liang; Jordan Mortensen; Vani Nilakantan; William E Sweeney; Frank Park
Journal:  Pediatr Nephrol       Date:  2010-03-13       Impact factor: 3.714

7.  Autosomal recessive polycystic kidney disease: outcomes from a single-center experience.

Authors:  Rhona Capisonda; Veronique Phan; Jeffrey Traubuci; Alan Daneman; J Williamson Balfe; Lisa M Guay-Woodford
Journal:  Pediatr Nephrol       Date:  2003-01-21       Impact factor: 3.714

8.  Abnormal glyceraldehyde-3-phosphate dehydrogenase binding and glycolytic flux in Autosomal Dominant Polycystic Kidney Disease after a mild oxidative stress.

Authors:  C Dioudis; G Dimitrios; T H Thomas; I C West
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

Review 9.  New treatment paradigms for ADPKD: moving towards precision medicine.

Authors:  Matthew B Lanktree; Arlene B Chapman
Journal:  Nat Rev Nephrol       Date:  2017-10-09       Impact factor: 28.314

10.  Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience.

Authors:  Abdullah Ozkok; Timur Selcuk Akpinar; Fatih Tufan; Nilufer Alpay Kanitez; Mukremin Uysal; Metban Guzel; Yasar Caliskan; Sabahat Alisir; Halil Yazici; Tevfik Ecder
Journal:  Clin Exp Nephrol       Date:  2012-10-20       Impact factor: 2.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.